We use Google Analytics to see which pages are read and how the site is used, so we know what to improve. This only runs if you accept. See our privacy notice for details.

Dáil

Written answer

Medicinal Products

476. Deputy Gillian Toole asked the Minister for Health if information (details supplied) in relation to a series of matters regarding the policy, clinical and financial rationale for restricting access to long-acting injectable buprenorphine will be provided; and if she will make a statement on the matter. [33481/26]

Comment on this